The effect of longitudinal body weight and CD4 cell progression for the survival of HIV/AIDS patients

It is about half a century since the HIV epidemic has been a menace to this world. Since then, several risk factors have been investigated for the prevalence of the disease, and the survival of Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS) patients. The main purpose of...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Gebru Gebremeskel Gebrerufael, Zeytu Gashaw Asfaw, Dessie Melese Chekole
Formato: article
Lenguaje:EN
Publicado: Taylor & Francis Group 2021
Materias:
art
R
Acceso en línea:https://doaj.org/article/74c0bad0dbb74c1c90c6e768335b5891
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:74c0bad0dbb74c1c90c6e768335b5891
record_format dspace
spelling oai:doaj.org-article:74c0bad0dbb74c1c90c6e768335b58912021-11-04T15:00:45ZThe effect of longitudinal body weight and CD4 cell progression for the survival of HIV/AIDS patients2331-205X10.1080/2331205X.2021.1986269https://doaj.org/article/74c0bad0dbb74c1c90c6e768335b58912021-01-01T00:00:00Zhttp://dx.doi.org/10.1080/2331205X.2021.1986269https://doaj.org/toc/2331-205XIt is about half a century since the HIV epidemic has been a menace to this world. Since then, several risk factors have been investigated for the prevalence of the disease, and the survival of Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS) patients. The main purpose of the current study was to examine the current patient status in contrast with baseline facts and investigate the separate and joint effects of body weight and CD4 cell count progression for the survival of HIV/AIDS patients. A retrospective cohort study was conducted among HIV/AIDS patients, who were under Antiretroviral Therapy (ART) follow-up during 11 September 2013—5 September 2016 at Mekelle General Hospital, Ethiopia. A total of 216 HIV/AIDS patients were selected by using a systematic random sampling technique. Based on the complexity of the data and the desired objectives of the study, the authors have considered linear mixed-effects model (LMM) for continuous responses body weight and CD4 count, a Cox proportional hazard model for the survival outcome (time to death) and Joint model of longitudinal and survival outcome. The mean age, hemoglobin level, and body weight of HIV/AIDS patients at the start of ART were 34.8 years, 13.6 g/100 ml, and 49.2 kg, respectively. The average number of baseline CD4 cells count was 311.04 cells per mm3 with a standard deviation of 161 cells per mm3 of blood implying that patients were at a higher risk of getting HIV/AIDS-related illness. Out of 216 HIV/AIDS patients, 134 (62%) were female and 130 (60%) lived in an urban area. Similarly, among the sampled HIV/AIDS patients 23 (10.6%) were with HIV/TB co-infected. The present study has concerned on the comparison of separate and joint modeling. The results clearly demonstrate that the joint modeling of longitudinally CD4 count and weight measurements with survival outcomes fit the current dataset better than those obtained from the separate model, of course the authors realize in some specific cases both separate and joint analysis were consistent. However, the joint models were simpler as compared to the separate models as their effective member of parameters was smaller. In the analysis of joint modeling of longitudinal $$\sqrt {CD4 cell } $$ and log (body-weight) progression with survival time to death of HIV/AIDS patients, considered various sub-models and various significant factors were identified. In the event process the sub-model, Baseline CD4, fair, and good adherence, HIV/Tuberculosis (TB), and sex were significant factors of risk to short survival Time-to-Death on HIV/AIDS patients. In the first longitudinal process sub-model, Baseline CD4, Ambulatory functional status, HIV/TB (yes), Time*Ambulatory functional status, Time*Working functional status, and Time*Baseline CD4 were the significant factors of $$\sqrt {CD4 cell } $$ count progression. Moreover, In the second longitudinal process sub-model, visit time of follow-up, age, sex (male), baseline weight, Time*Ambulatory, and Time*Working functional status were the significant factors of log 10 (bodyweight) progression. In the present study, appropriate models were chosen and important significant factors also identified. Hence, the authors strongly suggest that special intervention, clinical practice, and health policy revision should be made on the risk factors that potentially determine the survival of HIV/AIDS patients.Gebru Gebremeskel GebrerufaelZeytu Gashaw AsfawDessie Melese ChekoleTaylor & Francis Grouparticleartcd4 cellhiv/aidslongitudinal data analysisstatistical joint modelingMedicineRENCogent Medicine, Vol 8, Iss 1 (2021)
institution DOAJ
collection DOAJ
language EN
topic art
cd4 cell
hiv/aids
longitudinal data analysis
statistical joint modeling
Medicine
R
spellingShingle art
cd4 cell
hiv/aids
longitudinal data analysis
statistical joint modeling
Medicine
R
Gebru Gebremeskel Gebrerufael
Zeytu Gashaw Asfaw
Dessie Melese Chekole
The effect of longitudinal body weight and CD4 cell progression for the survival of HIV/AIDS patients
description It is about half a century since the HIV epidemic has been a menace to this world. Since then, several risk factors have been investigated for the prevalence of the disease, and the survival of Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS) patients. The main purpose of the current study was to examine the current patient status in contrast with baseline facts and investigate the separate and joint effects of body weight and CD4 cell count progression for the survival of HIV/AIDS patients. A retrospective cohort study was conducted among HIV/AIDS patients, who were under Antiretroviral Therapy (ART) follow-up during 11 September 2013—5 September 2016 at Mekelle General Hospital, Ethiopia. A total of 216 HIV/AIDS patients were selected by using a systematic random sampling technique. Based on the complexity of the data and the desired objectives of the study, the authors have considered linear mixed-effects model (LMM) for continuous responses body weight and CD4 count, a Cox proportional hazard model for the survival outcome (time to death) and Joint model of longitudinal and survival outcome. The mean age, hemoglobin level, and body weight of HIV/AIDS patients at the start of ART were 34.8 years, 13.6 g/100 ml, and 49.2 kg, respectively. The average number of baseline CD4 cells count was 311.04 cells per mm3 with a standard deviation of 161 cells per mm3 of blood implying that patients were at a higher risk of getting HIV/AIDS-related illness. Out of 216 HIV/AIDS patients, 134 (62%) were female and 130 (60%) lived in an urban area. Similarly, among the sampled HIV/AIDS patients 23 (10.6%) were with HIV/TB co-infected. The present study has concerned on the comparison of separate and joint modeling. The results clearly demonstrate that the joint modeling of longitudinally CD4 count and weight measurements with survival outcomes fit the current dataset better than those obtained from the separate model, of course the authors realize in some specific cases both separate and joint analysis were consistent. However, the joint models were simpler as compared to the separate models as their effective member of parameters was smaller. In the analysis of joint modeling of longitudinal $$\sqrt {CD4 cell } $$ and log (body-weight) progression with survival time to death of HIV/AIDS patients, considered various sub-models and various significant factors were identified. In the event process the sub-model, Baseline CD4, fair, and good adherence, HIV/Tuberculosis (TB), and sex were significant factors of risk to short survival Time-to-Death on HIV/AIDS patients. In the first longitudinal process sub-model, Baseline CD4, Ambulatory functional status, HIV/TB (yes), Time*Ambulatory functional status, Time*Working functional status, and Time*Baseline CD4 were the significant factors of $$\sqrt {CD4 cell } $$ count progression. Moreover, In the second longitudinal process sub-model, visit time of follow-up, age, sex (male), baseline weight, Time*Ambulatory, and Time*Working functional status were the significant factors of log 10 (bodyweight) progression. In the present study, appropriate models were chosen and important significant factors also identified. Hence, the authors strongly suggest that special intervention, clinical practice, and health policy revision should be made on the risk factors that potentially determine the survival of HIV/AIDS patients.
format article
author Gebru Gebremeskel Gebrerufael
Zeytu Gashaw Asfaw
Dessie Melese Chekole
author_facet Gebru Gebremeskel Gebrerufael
Zeytu Gashaw Asfaw
Dessie Melese Chekole
author_sort Gebru Gebremeskel Gebrerufael
title The effect of longitudinal body weight and CD4 cell progression for the survival of HIV/AIDS patients
title_short The effect of longitudinal body weight and CD4 cell progression for the survival of HIV/AIDS patients
title_full The effect of longitudinal body weight and CD4 cell progression for the survival of HIV/AIDS patients
title_fullStr The effect of longitudinal body weight and CD4 cell progression for the survival of HIV/AIDS patients
title_full_unstemmed The effect of longitudinal body weight and CD4 cell progression for the survival of HIV/AIDS patients
title_sort effect of longitudinal body weight and cd4 cell progression for the survival of hiv/aids patients
publisher Taylor & Francis Group
publishDate 2021
url https://doaj.org/article/74c0bad0dbb74c1c90c6e768335b5891
work_keys_str_mv AT gebrugebremeskelgebrerufael theeffectoflongitudinalbodyweightandcd4cellprogressionforthesurvivalofhivaidspatients
AT zeytugashawasfaw theeffectoflongitudinalbodyweightandcd4cellprogressionforthesurvivalofhivaidspatients
AT dessiemelesechekole theeffectoflongitudinalbodyweightandcd4cellprogressionforthesurvivalofhivaidspatients
AT gebrugebremeskelgebrerufael effectoflongitudinalbodyweightandcd4cellprogressionforthesurvivalofhivaidspatients
AT zeytugashawasfaw effectoflongitudinalbodyweightandcd4cellprogressionforthesurvivalofhivaidspatients
AT dessiemelesechekole effectoflongitudinalbodyweightandcd4cellprogressionforthesurvivalofhivaidspatients
_version_ 1718444777955917824